Home > Press > Moscow State University Buys Russia's First IBM Blue Gene Supercomputer
Abstract:
Leading Russian University to Use the World's Most Powerful Computing System for Breakthrough Scientific Research
Moscow State University (MSU) and IBM (NYSE: IBM) today announced details of an agreement to install a Blue Gene/P supercomputer at the Department of Computational Mathematics and Cybernetics. The new supercomputer, the first installation of the world famous Blue Gene computer in Russia, will be used for fundamental research in nanotechnology, new materials and life sciences.
"As Russia's leading academic institution, we are very proud that Moscow State University should join the ranks of the world's leading research organisations to tackle some of the most complex and computer intensive problems known to man-kind -- from astrophysics, to molecular modelling," said Viktor Sadovnichiy, Rector of Moscow State University. "This agreement with IBM heralds a new era of supercomputing in Russia."
Moscow State University has agreed to buy two racks of the Blue Gene/P system containing 8.192 densely packed microprocessors. The resulting supercomputer is expected to run at 27.8 trillion operations per second (Tflop/s), 2,600 times faster than today's fastest home PC. Based on the current Top500.org list, the MSU system would today be amongst the top 50 most powerful supercomputers in the world.
Blue Gene uses a fraction of the energy of Russia's other most powerful supercomputers and requires significantly less physical space to house the system. One rack of Blue Gene/P is equivalent in size to a domestic refrigerator and is at least seven times more energy-efficient than any other design. The 'modular' and scalable design of Blue Gene means that MSU researchers can add racks as computing requirements grow.
"IBM is working with top universities and government agencies around the world to deliver the next generation of supercomputers that combine different types of processors to increase compute power while reduce energy and space costs," said Kirill Korniliev, Country General Manager, IBM East Europe & Asia. "Our agreement with Moscow State University demonstrates not only our commitment to Russia's leading university, but to Russia's national scientific agenda."
Blue Gene/P is the second generation of the world's most powerful supercomputer. Since 2004 IBM's Blue Gene has led the Top500 list of the world's most powerful supercomputers (www.top500.org). Because of its unique design that allows for the dense packaging of processors, memory and interconnecting circuits, Blue Gene is also the world's most energy efficient and compact supercomputer.
MSU plans for the system to be operational by April 2008.
Note to Editors: Broadcast-quality video clips of Blue Gene systems, and of IBM Vice President David Turek discussing Blue Gene/P are available for download by registered journalists here.
####
For more information, please click here
Contacts:
IBM U.S.
Mike Corrado
914-766-4635
IBM East Europe/ Asia (Russia and CIS)
Jonathan Batty
Tel.: +7 495 775 8800
E-mail:
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
New-Contracts/Sales/Customers
Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center: New Advanced Imaging Center Powered by Two MuVi and LCS SPIM Microscopes March 25th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Veeco Announces Aledia Order of 300mm MOCVD Equipment for microLED Displays: Propel™ Platform First 300mm System with EFEM Designed for Advanced Display Applications October 20th, 2020
GREENWAVES TECHNOLOGIES Announces Next Generation GAP9 Hearables Platform Using GLOBALFOUNDRIES 22FDX Solution October 16th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||